MedTrace Logo

Interest of tDCS in Help for Supporting Alcohol Abstinence

NCT03287154 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2026-01-13

No results posted yet for this study

Summary

The aim of the study is to evaluate in patients with alcohol disorder and forehand weaned the efficiency of 10 active tDCS sessions versus 10 sham (placebo) sessions in the support of abstinence at 3 months.

Conditions

  • Alcoholic Intoxication

Interventions

DEVICE

Active tDCS stimulations

20 min, 2mA

DEVICE

Sham tDCS

20 min, Sham

Sponsors & Collaborators

  • Centre Hospitalier Henri Laborit

    lead OTHER

Principal Investigators

  • Nematollah Jaafari, Professor · Centre Hospitalier Henri Laborit

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-08
Primary Completion
2025-02-07
Completion
2025-08-07

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03287154 on ClinicalTrials.gov